logo

For the Inventor, By the Inventor

New York, NY, United States of America

Coley Pharmaceutical Group, Inc.


USPTO Granted Patents = 41

% Expired Patents = 78.0



Forward Citations = 1,578

Loading Chart...
Loading Chart...

55 inventors (with patents filed for the assignee):

goldMedal Arthur Mertz Krieg (28 out of 69 patents)

silverMedal Dennis M Klinman (12 out of 54 patents)

bronzeMedal Alfred D Steinberg (12 out of 15 patents)

4.  Jörg Vollmer (11 out of 17 patents)

5.  Eugen Uhlmann (8 out of 80 patents)

6.  Grayson B Lipford (5 out of 23 patents)

7.  Ulrike Samulowitz (5 out of 5 patents)

8.  Joel N Kline (4 out of 13 patents)

9.  Tushar A Kshirsagar (3 out of 48 patents)

10.  Heather Lynn Davis (3 out of 16 patents)

11.  Robert L Bratzler (3 out of 6 patents)

12.  Marion Jurk (3 out of 10 patents)

13.  Philip D Heppner (3 out of 64 patents)

14.  Alexandra Forsbach (3 out of 3 patents)

15.  George W Griesgraber (2 out of 108 patents)


Core Competencies:
Immunostimulatory Oligonucleotides
Pneumococcal Vaccine
Nucleic Acid Compositions
Immunomodulatory Oligonucleotides
Cancer Treatment
Hepatitis C Virus
Toll-Like Receptor Antagonists
Immunostimulatory Nucleic Acids
Phosphorothioate Oligonucleotide
Small Molecule Analogues
Infectious Disease Prevention
Asthma Treatment

41 patents:

1. 9453059 - Immunostimulatory oligonucleotides (2016-09-27),
2. 9205143 - Pneumococcal vaccine and uses thereof (2015-12-08),
3. 8354522 - Immunostimulatory oligoribonucleotides (2013-01-15),
4. 8309527 - Immunomodulatory oligonucleotides (2012-11-13),
5. 8304396 - Immunostimulatory nucleic acids (2012-11-06),
6. 8283328 - Immunostimulatory nucleic acids (2012-10-09),
7. 8258106 - Immunostimulatory nucleic acid molecules (2012-09-04),
8. 8198251 - Combination motif immune stimulatory oligonucleotides with improved activity (2012-06-12),
9. 8188254 - C-class oligonucleotide analogs with enhanced immunostimulatory potency (2012-05-29),
10. 8158592 - Immunostimulatory nucleic acid molecules (2012-04-17),
11. 8129351 - Immunostimulatory nucleic acid molecules (2012-03-06),
12. 8114848 - Immunomodulatory oligonucleotides (2012-02-14),
13. 8114419 - Nucleic acid compositions for stimulating immune responses (2012-02-14),
14. 8058249 - Immunostimulatory nucleic acid molecules (2011-11-15),
15. 8008266 - Methods of treating cancer using immunostimulatory oligonucleotides (2011-08-30),
Company Overview
Coley Pharmaceutical Group, Inc. is a biotechnology company based in New York, specializing in the development of innovative immunotherapeutics. The company focuses on immunostimulatory oligonucleotides and nucleic acid compositions that target the immune system to enhance responses against cancer and infectious diseases. Their research encompasses various domains, including CpG nucleic acids and Toll-like receptor antagonists, aiming to advance treatment options for cancer and develop effective vaccines, such as those for pneumococcal infections.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

41 Patents

#225 in New York, NY

#519 in New York

#8,433 in US

#16,686 in the World

New York, NY (US)
New York, NY, United States of America

Coley Pharmaceutical Group, Inc.

Forward Citations = 1,578

55 inventors:

goldMedal Arthur Mertz Krieg (28 out of 69 patents)

silverMedal Dennis M Klinman (12 out of 54 patents)

bronzeMedal Alfred D Steinberg (12 out of 15 patents)

4.  Jörg Vollmer (11 out of 17 patents)

5.  Eugen Uhlmann (8 out of 80 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Coley Pharmaceutical Group, Inc.. Retrieved from https://idiyas.com/company/coley-pharmaceutical-group

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…